Literature DB >> 16611865

Morphological and quantitative assessment of mast cells in rheumatoid arthritis associated non-specific interstitial pneumonia and usual interstitial pneumonia.

S R Atkins1, E L Matteson, J L Myers, J H Ryu, T Bongartz.   

Abstract

BACKGROUND: The role of mast cells in extra-articular manifestations of rheumatoid arthritis (RA) has not been studied so far.
OBJECTIVE: To characterise and quantify mast cells in RA associated interstitial pneumonia (IP) by an immunohistological study.
METHODS: Lung biopsy specimens from 15 patients with RA associated IP, 12 patients with idiopathic IP, and 5 control patients were stained with antibodies directed against tryptase (mast cell marker). Morphological characterisation of stained specimens was carried out and staining was quantified by computer assisted image analysis.
RESULTS: Tryptase staining showed the marked presence of mast cells in idiopathic IP and in RA associated IP. A significant difference in stained tissue area was found between RA associated IP (2.6%, IQR 2.0-3.2%, p = 0.015) and idiopathic IP (3.1%, IQR 1.8-3.7%, p = 0.003) compared with control tissue specimens (1.0%, IQR 0.7-1.5%). The extent of mast cell infiltration correlated well and inversely with pulmonary function variables.
CONCLUSIONS: Mast cell infiltrates are present in RA associated IP and idiopathic IP. The observed correlation of pulmonary function and mast cell numbers would be consistent with the proposed role of mast cell mediators in the promotion of fibrogenesis. The findings provide a rationale for studying functional aspects of mast cell involvement in the pathogenesis of RA associated lung disease.

Entities:  

Mesh:

Year:  2006        PMID: 16611865      PMCID: PMC1798120          DOI: 10.1136/ard.2005.043877

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  16 in total

1.  A specific chymase inhibitor, NK3201, suppresses bleomycin-induced pulmonary fibrosis in hamsters.

Authors:  Masato Sakaguchi; Shinji Takai; Denan Jin; Yukiko Okamoto; Michiko Muramatsu; Shokei Kim; Mizuo Miyazaki
Journal:  Eur J Pharmacol       Date:  2004-06-16       Impact factor: 4.432

2.  Mast cell tryptase stimulates human lung fibroblast proliferation via protease-activated receptor-2.

Authors:  I A Akers; M Parsons; M R Hill; M D Hollenberg; S Sanjar; G J Laurent; R J McAnulty
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2000-01       Impact factor: 5.464

3.  Mouse bone marrow-derived mast cells cocultured with fibroblasts. Morphology and stimulation-induced release of histamine, leukotriene B4, leukotriene C4, and prostaglandin D2.

Authors:  F Levi-Schaffer; E T Dayton; K F Austen; A Hein; J P Caulfield; P M Gravallese; F T Liu; R L Stevens
Journal:  J Immunol       Date:  1987-11-15       Impact factor: 5.422

4.  Cells, collagen and idiopathic pulmonary fibrosis.

Authors:  R G Crystal; J D Fulmer; B J Baum; J Bernardo; K H Bradley; S D Bruel; N A Elson; G A Fells; V J Ferrans; J E Gadek; G W Hunninghake; O Kawanami; J A Kelman; B R Line; J A McDonald; B D McLees; W C Roberts; D M Rosenberg; P Tolstoshev; E Von Gal; S E Weinberger
Journal:  Lung       Date:  1978       Impact factor: 2.584

5.  Increased CD4+ T cell infiltrates in rheumatoid arthritis-associated interstitial pneumonitis compared with idiopathic interstitial pneumonitis.

Authors:  Carl Turesson; Eric L Matteson; Thomas V Colby; Zvezdana Vuk-Pavlovic; Robert Vassallo; Cornelia M Weyand; Henry D Tazelaar; Andrew H Limper
Journal:  Arthritis Rheum       Date:  2005-01

6.  A novel chymase inhibitor, 4-[1-([bis-(4-methyl-phenyl)-methyl]-carbamoyl)3-(2-ethoxy-benzyl)-4-oxo-azetidine-2-yloxy]-benzoic acid (BCEAB), suppressed cardiac fibrosis in cardiomyopathic hamsters.

Authors:  Shinji Takai; Denan Jin; Masato Sakaguchi; Satoru Katayama; Michiko Muramatsu; Minoru Sakaguchi; Eiko Matsumura; Shokei Kim; Mizuo Miyazaki
Journal:  J Pharmacol Exp Ther       Date:  2003-04       Impact factor: 4.030

7.  Extra-articular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 years.

Authors:  C Turesson; W M O'Fallon; C S Crowson; S E Gabriel; E L Matteson
Journal:  Ann Rheum Dis       Date:  2003-08       Impact factor: 19.103

8.  Fibroblasts maintain the phenotype and viability of the rat heparin-containing mast cell in vitro.

Authors:  F Levi-Schaffer; K F Austen; J P Caulfield; A Hein; W F Bloes; R L Stevens
Journal:  J Immunol       Date:  1985-11       Impact factor: 5.422

9.  Mast cell differentiation depends on T cells and granule synthesis on fibroblasts.

Authors:  S Davidson; A Mansour; R Gallily; M Smolarski; M Rofolovitch; H Ginsburg
Journal:  Immunology       Date:  1983-03       Impact factor: 7.397

10.  Mast cells: a cellular link between autoantibodies and inflammatory arthritis.

Authors:  David M Lee; Daniel S Friend; Michael F Gurish; Christophe Benoist; Diane Mathis; Michael B Brenner
Journal:  Science       Date:  2002-09-06       Impact factor: 47.728

View more
  3 in total

Review 1.  Image analysis tools for evaluation of microscopic views of immunohistochemically stained specimen in medical research-a review.

Authors:  Keerthana Prasad; Gopalakrishna K Prabhu
Journal:  J Med Syst       Date:  2011-05-17       Impact factor: 4.460

Review 2.  Rheumatoid arthritis-associated interstitial lung disease: the relevance of histopathologic and radiographic pattern.

Authors:  Eunice J Kim; Harold R Collard; Talmadge E King
Journal:  Chest       Date:  2009-11       Impact factor: 9.410

3.  Inmunohistochemical detection of mastocytes in tissue from patients with actinic prurigo.

Authors:  Eduwiges Martínez-Luna; Ronell Bologna-Molina; Adalberto Mosqueda-Taylor; Juan-Carlos Cuevas-González; Erika Rodríguez-Lobato; María-Abril Martínez-Velasco; María-Elisa Vega-Memíje
Journal:  J Clin Exp Dent       Date:  2015-12-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.